TWFG:NSD-TWFG, Inc. Class A Common Stock (USD)

COMMON STOCK | Insurance Brokers |

Last Closing

USD 27.34

Change

+0.69 (+2.59)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Insurance Brokers

Symbol Name Price(Change) Market Cap
ERIE Erie Indemnity Company

+11.22 (+2.14%)

USD 27.24B
CRVL CorVel Corp

+0.39 (+0.12%)

USD 5.43B
BWIN The Baldwin Insurance Group, I..

+1.30 (+2.65%)

USD 3.22B
GOCO GoHealth Inc.

+0.39 (+4.25%)

USD 0.20B
EHTH eHealth Inc

-0.14 (-3.37%)

USD 0.11B
FANH Fanhua Inc

-0.01 (-0.75%)

USD 0.07B
HUIZ Huize Holding Ltd

N/A

USD 0.04B
RELIW Reliance Global Group Inc

N/A

USD 0.04B
TIRX Tian Ruixiang Holdings Ltd

+0.02 (+1.04%)

USD 4.03M
RELI Reliance Global Group Inc

-0.10 (-3.70%)

USD 3.42M

ETFs Containing TWFG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance Brokers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector